261 related articles for article (PubMed ID: 3876465)
1. Lymphokine-activated killer cells: a new approach to immunotherapy of cancer.
Rosenberg S
J Natl Cancer Inst; 1985 Oct; 75(4):595-603. PubMed ID: 3876465
[No Abstract] [Full Text] [Related]
2. Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.
Rosenberg SA
Important Adv Oncol; 1986; ():55-91. PubMed ID: 3330541
[No Abstract] [Full Text] [Related]
3. Immunotherapy of cancer: the end of the beginning?
Durant JR
N Engl J Med; 1987 Apr; 316(15):939-41. PubMed ID: 3493434
[No Abstract] [Full Text] [Related]
4. [A new approach in the treatment of metastatic melanoma: adoptive immunotherapy using lymphokine-activated killer cells and interleukin 2].
Keilholz U; Welters H; Dummer R; Tilgen W; Hunstein W
Hautarzt; 1988 Jun; 39(6):378-81. PubMed ID: 3261288
[TBL] [Abstract][Full Text] [Related]
5. [The activation of natural killer cells. A new approach to adoptive immunotherapy of tumors].
Schwarz R
Fortschr Med; 1988 Oct; 106(29):579-80. PubMed ID: 3266178
[No Abstract] [Full Text] [Related]
6. Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes.
Rosenberg SA; Lotze MT
Annu Rev Immunol; 1986; 4():681-709. PubMed ID: 3518753
[No Abstract] [Full Text] [Related]
7. [Use of interleukin 2-activated lymphocytes (LAK cells) in adoptive immunotherapy of neoplasms].
Robak T
Pol Tyg Lek; 1988 Nov; 43(47):1491-5. PubMed ID: 3266975
[No Abstract] [Full Text] [Related]
8. [Adoptive immunotherapy with interleukin-2 and with interleukin-2 activated lymphocytes].
Eggermont AM; Stoter G; Jansen RL; Bolhuis RL
Ned Tijdschr Geneeskd; 1989 Jul; 133(28):1387-92. PubMed ID: 2677757
[No Abstract] [Full Text] [Related]
9. "Lymphokine activated killing" as treatment for human cancer: clinical extrapolations from laboratory studies with interleukin-2 expanded leukocytes.
Sondel PM; Hank JA; Kohler PC; Chen BP; Sosman J
Prog Clin Biol Res; 1989; 288():151-60. PubMed ID: 2654949
[No Abstract] [Full Text] [Related]
10. Interleukin-2 and lymphokine-activated killer cell therapy for gastrointestinal cancer.
Guillou P
Acta Chir Scand Suppl; 1989; 549():26-30. PubMed ID: 2784604
[No Abstract] [Full Text] [Related]
11. Mechanistic aspects of successful immunotherapy of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin-2.
Mulé JJ; Rosenberg SA
Prog Clin Biol Res; 1987; 244():79-91. PubMed ID: 3310006
[No Abstract] [Full Text] [Related]
12. [Adoptive immunotherapy: a new therapeutic approach to cancer based on interleukin 2].
Sculier JP; Bron D; Delforge A; Stryckmans P; Klastersky J
Rev Med Brux; 1987 Mar; 8(3):133-9. PubMed ID: 3495843
[No Abstract] [Full Text] [Related]
13. Antimetastatic activity of lymphokine-activated killer cells to rat fibrosarcoma (WBT-2M) and rat mammary carcinoma (SST-2).
Ba DN; Wang ZH; Li XB; Li DJ
Chin Med J (Engl); 1987 Jan; 100(1):2-7. PubMed ID: 3109819
[No Abstract] [Full Text] [Related]
14. Treatment of cancer with lymphokine-activated killer cells and interleukin-2.
N Engl J Med; 1987 Oct; 317(15):961-3. PubMed ID: 3498120
[No Abstract] [Full Text] [Related]
15. Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cells.
Fagan EA; Eddleston AL
Gut; 1987 Feb; 28(2):113-6. PubMed ID: 3549471
[No Abstract] [Full Text] [Related]
16. Lymphokine activated killer cells research in China.
Ba DN
Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(3):170-4. PubMed ID: 3064089
[No Abstract] [Full Text] [Related]
17. [Treatment of malignant tumors by interleukin 2 and LAK cells].
Degos L
Nouv Rev Fr Hematol (1978); 1988; 30(1-2):119-22. PubMed ID: 3260373
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of cytotoxic lymphocytes potentially relevant for cellular immunotherapy of cancer: implications for designing clinical strategies.
Triebel F; Hercend T
Prog Clin Biol Res; 1987; 244():207-11. PubMed ID: 3498949
[No Abstract] [Full Text] [Related]
19. [Immunotherapy of cancer with interleukin-2 and with interleukin-2 activated cells].
Osanto S; Brand A; van Rood JJ; Cleton FJ
Ned Tijdschr Geneeskd; 1989 Jul; 133(28):1392-5. PubMed ID: 2677758
[No Abstract] [Full Text] [Related]
20. [Adoptive immunotherapy using cytapheresis].
Takago H; Sasakawa H; Kanizawa Y; Nojiri H; Ueno Y
Rinsho Ketsueki; 1986 Jul; 27(7):1242-6. PubMed ID: 3491233
[No Abstract] [Full Text] [Related]
[Next] [New Search]
